Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Eugia Pharma Specialities Limited, is an unlisted public company incorporated on 17 April, 2013. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 800.00 cr and the total paid-up capital is INR 621.01 cr.
Eugia Pharma Specialities Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 14.54% over the previous year. At the same time, it's book networth has increased by 29.6%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
18.34%
14.54%
-27.05%
29.6%
124.38%
26.7%
1.25
-1.08
-7.73
-17.72
-9.62
0.72
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(7)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Ragunathan Kannan | 00523576 | 3 years |
| Director | Madan Mohan Reddy Mettu
Shareholder
|
01284266 | 12 years |
| Director | Sundari Raviprasad Pisupati | 01908852 | 3 years |
| Director | Santhanam Subramanian | 03516515 | 3 years |
| Director | Veerayya Chowdary Kosaraju | 08485334 | 3 years |
| CEO | Yugandhar Puvvala | <HIDDEN> | 3 years |
| Director | Yugandhar Puvvala | 09379957 | 3 years |
| CS | Venkat Reddy Kupireddy | <HIDDEN> | 6 years |
| Kmp | Vallamkondu Aravind Kumar | <HIDDEN> | 1 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| TRUST AMC TRUSTEE PRIVATE LIMITED |
Active
|
50.0 L | 1 | Maharashtra |
| NU GENES AGRI BUSINESS PRIVATE LIMITED |
Active
|
1.8 L | 1 | Telangana |
| SATHGURU MANAGEMENT CONSULTANTS PVT LTD |
Active
|
30.0 L | 1 | Telangana |
| FERNANDEZ FOUNDATION |
Active
|
24.0 L | 1 | Telangana |
| SATHGURU SOFTWARE PRODUCTS PRIVATE LIMITED |
Active
|
6.8 Cr | 1 | Telangana |
| PREMIER ENERGIES LIMITED |
Active
|
45.1 Cr | 1 | Telangana |
| AUROBINDO PHARMA LTD |
Active
|
58.1 Cr | 1 | Telangana |
| OREMSI PLASTICS PRIVATE LIMITED |
Strike Off
|
1.3 L | 1 | Telangana |
| CUREPRO PARENTERALS LIMITED |
Amalgamated
|
13.3 Cr | 2 | Telangana |
| AURONEXT PHARMA PRIVATE LIMITED |
Amalgamated
|
125.0 Cr | 1 | Telangana |
| THERANYM BIOLOGICS PRIVATE LIMITED |
Active
|
10.0 L | 2 | Telangana |
| AUROZEST PRIVATE LIMITED |
Active
|
10.0 L | 1 | Telangana |
| AURO VACCINES PRIVATE LIMITED |
Active
|
10.0 L | 1 | Telangana |
| CREST EXCIPIENTS LLP |
Strike Off
|
1.3 L | 1 | Telangana |
| EUGIA STERILES PRIVATE LIMITED |
Active
|
44.2 Cr | 2 | Telangana |
| CURATEQ BIOLOGICS PRIVATE LIMITED |
Active
|
100.0 Cr | 1 | Telangana |
| PRAVESHA INDUSTRIES PRIVATE LIMITED |
Active
|
10.0 Cr | 1 | Telangana |
| EUGIA SEZ PRIVATE LIMITED |
Active
|
4.0 Cr | 4 | Telangana |
| RAINBOW SPECIALITY HOSPITALS PRIVATE LIMITED |
Active
|
18.0 Cr | 1 | Telangana |
| RAINBOW CHILDREN'S MEDICARE LIMITED |
Active
|
101.6 Cr | 1 | Telangana |
| QULE PHARMA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Andhra Pradesh |
| AUROACTIVE PHARMA PRIVATE LIMITED |
Active
|
100.0 Cr | 1 | Telangana |
| TERGENE BIOTECH LIMITED |
Active
|
45.0 Cr | 1 | Telangana |
| APITORIA PHARMA PRIVATE LIMITED |
Active
|
99.0 Cr | 1 | Telangana |
| LYFIUS PHARMA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Andhra Pradesh |
| ANANT RAJ LIMITED |
Active
|
68.4 Cr | 1 | Haryana |
| GENOME FOUNDATION |
Active
|
81.5 L | 1 | Telangana |
| GMR VARALAKSHMI FOUNDATION |
Active
|
0.0 | 1 | Andhra Pradesh |
| DIVI'S LABORATORIES LIMITED |
Active
|
53.0 Cr | 1 | Telangana |
| MY HOME INDUSTRIES PRIVATE LIMITED |
Active
|
51.0 Cr | 1 | Telangana |
| CCL PRODUCTS (INDIA) LIMITED |
Active
|
26.7 Cr | 1 | Andhra Pradesh |
| NUZIVEEDU SEEDS LIMITED |
Active
|
86.3 Cr | 1 | Telangana |
| RELIANCE INDUSTRIES LIMITED |
Active
|
6,766.2 Cr | 1 | Maharashtra |
| TATA MOTORS LIMITED |
Active
|
736.2 Cr | 1 | Maharashtra |
| RELIANCE JIO INFOCOMM LIMITED |
Active
|
45,000.0 Cr | 1 | Gujarat |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| EUGIA SEZ PRIVATE LIMITED | Telangana | 2021 | ₹ 4.0 Cr |
| EUGIA INJECTABLE INC.,USA | United States | - | - |
| EUGIA STERILES PRIVATE LIMITED | Telangana | 2020 | ₹ 44.2 Cr |
| Eugia Pharma B.V | Netherlands | - | - |
| Eugia pharma (malta) limited | Malta | - | - |
| Eugia (uk) limited | United Kingdom | - | - |
| Eugia Pharma Inc Canada | Canada | - | - |
| Eugia Pharma (Austalia) PTY Limited | Australia | - | - |
| Eugia pharma industria farmaceutica limitada | Brazil | - | - |
| Eugia Inc | United States | - | - |
| Eugia pharma colombia inc | Colombia | - | - |
The incorporation date of EUGIA PHARMA SPECIALITIES LIMITED is 17 April, 2013
The authorized share capital of EUGIA PHARMA SPECIALITIES LIMITED is INR ₹ 800.0 Cr.
The paid-up capital of EUGIA PHARMA SPECIALITIES LIMITED is INR ₹ 621.0 Cr.
The registered address of EUGIA PHARMA SPECIALITIES LIMITED is Plot No.2, Maitrivihar, NA Ameerpet Hyderabad Telangana - 500038
The CIN number of EUGIA PHARMA SPECIALITIES LIMITED is U24297TG2013PLC087048.
Expand
Delete
Collapse
See
details
